Results 1 to 10 of about 4,808,860 (205)
Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version) [PDF]
Zhongguo aizheng zazhi, 2022 Recently, advances in organoid technology have opened new avenues for the development of novel models of human cancer. Patient-derived tumor organoids retain phenotypes such as histopathological, genetic and molecular features of the original tumor.
Society of Cancer Multidisciplinary Diagnosis and Treatment, China Anti-Cancer Association The +1 more
doaj +2 more sources
Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) [PDF]
Zhongguo aizheng zazhi, 2022 Neoadjuvant therapy has become one of the standard treatments in early breast cancer. In 2019, China breast cancer neoadjuvant therapy expert group discussed and expounded the purpose, indication, evaluation criteria, surgical operation principles and ...
Expert group of expert consensus on neoadjuvant treatment of breast cancer in China ( edition)
doaj +1 more source
Expert consensus on diagnosis, treatment and fertility management of young breast cancer patients
Journal of the National Cancer Center, 2021 Breast cancer in young females is a relatively common disease in China. Young breast cancer has aggressive clinical and pathological features. During the treatment of young females with breast cancer, issues involving the choice of surgical methods ...
Committee of Diagnosis, Treatment, and Fertility Management of Chinese Young Breast Cancer Patients
doaj +1 more source
DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors
Scientific Reports, 2023 Role of DNA damage and demethylation on anticancer activity of DNA methyltransferase inhibitors (DNMTi) remains undefined. We report the effects of DNMT1 gene deletion/disruption (DNMT1 −/− ) on anticancer activity of a class of DNMTi in vitro, in vivo ...
Angelo B. A. Laranjeira +5 more
doaj +1 more source
Radiation Oncology, 2023 Purpose The aim was to assess the feasibility of online adaptive radiotherapy (oART) for bladder cancer using a focal boost by focusing on the quality of the online treatment plan and automatic target delineation, duration of the workflow and performance
Sana Azzarouali +10 more
doaj +1 more source
Rethinking Oncologic Treatment Strategies with Interleukin-2
Cells, 2023 High-dose recombinant human IL-2 (rhIL-2, aldesleukin) emerged as an important treatment option for selected patients with metastatic melanoma and metastatic renal cell carcinoma, producing durable and long-lasting antitumor responses in a small fraction
Brian Ko +4 more
doaj +1 more source
Plasma in Cancer Treatment [PDF]
Cancers, 2020 Cancer is the second leading cause of death worldwide, and while science has advanced significantly to improve the treatment outcome and quality of life in cancer patients, there are still many issues with the current therapies, such as toxicity and the development of resistance to treatment [...]
Angela Privat-Maldonado +1 more
openaire +3 more sources
Journal of Hematology & Oncology, 2021 Background Challenges remain on the selection of patients who potentially respond to a class of drugs that target epigenetics for cancer treatment. This study aims to investigate TET2/DNMT3A mutations and antitumor activity of a novel epigenetic agent in
Sherry X. Yang +7 more
doaj +1 more source